Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ABUS | Arbutus Biopharma Corp | HASTINGS DAVID C | Chief Financial Officer | Feb 02, 2024 | Sale | $2.31 | 9,593 | 22,184 | 181,907 | Feb 05, 2024, 07:54 PM | |
ETTX | Entasis Therapeutics Holdings Inc. | HASTINGS DAVID C | Director | Jul 07, 2022 | Option Exercise | $2.20 | 22,000 | 48,400 | 0 | Jul 11, 2022, 04:05 PM | |
ETTX | Entasis Therapeutics Holdings Inc. | HASTINGS DAVID C | Director | Jul 11, 2022 | Option Exercise | $2.20 | 27,500 | 60,500 | 0 | Jul 11, 2022, 04:05 PM | |
SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Mar 08, 2018 | Buy | $1.69 | 11,834 | 19,999 | 31,834 | Mar 12, 2018, 08:52 AM | |
SCYX | SCYNEXIS INC | HASTINGS DAVID C | Director | Jun 21, 2017 | Buy | $1.75 | 20,000 | 35,000 | 20,000 | Jun 22, 2017, 08:58 AM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Jun 04, 2014 | Option Exercise | $33.08 | 152,068 | 5,030,559 | 84,534 | Jun 06, 2014, 06:47 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Jun 05, 2014 | Option Exercise | $29.04 | 247,932 | 7,200,665 | 132,466 | Jun 06, 2014, 06:47 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Feb 14, 2014 | Option Exercise | $36.86 | 80,000 | 2,949,200 | 48,500 | Feb 18, 2014, 06:03 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Feb 18, 2014 | Option Exercise | $37.31 | 64,002 | 2,388,235 | 40,501 | Feb 18, 2014, 06:03 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Feb 13, 2014 | Sale | $40.27 | 405,998 | 16,350,825 | 211,499 | Feb 18, 2014, 06:03 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Sep 06, 2013 | Option Exercise | $21.13 | 200,000 | 4,225,000 | 108,500 | Sep 09, 2013, 04:13 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Feb 15, 2013 | Option Exercise | $14.55 | 200,000 | 2,910,800 | 108,500 | Feb 20, 2013, 04:33 PM | |
INCY | INCYTE CORP | HASTINGS DAVID C | Chief Financial Officer | Jun 09, 2011 | Sale | $11.43 | 200,000 | 2,285,500 | 108,500 | Jun 10, 2011, 05:06 PM |